EDIT vs LI
Editas Medicine Inc (EDIT) versus Li Auto Inc (LI) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Li Auto Inc (LI) is a auto manufacturers company listed on US.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported LI revenue for 2025-12-31 was $16.06B. Net income was $162.9M. Revenue was down 18.8% from 2024-12-31 to 2025-12-31. LI currently screens at market cap $26.62B and trailing P/E 24.2.
EDIT currently screens at market cap $375.2M. LI currently screens at market cap $26.62B and trailing P/E 24.2.
Not investment advice. Open the EDIT and LI stock pages for the full models.
Not investment advice.